Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Technical Feasibility of Testing Circulating Tumour DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.

NCT05415787 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT05415787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05415787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Technical Feasibility of Testing Circulating Tumour DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.
Lead sponsor
University Hospital, Tours
Phase
Observational
Overall status
Completed
Start date
August 18, 2022
Completion date
January 18, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor dna, metastatic prostate cancer